Get Live Data

GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK Board change

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,629.00
Bid: 1,629.00
Ask: 1,629.50
Change: -11.00 (-0.67%)
Spread: 0.50 (0.031%)
Open: 1,633.00
High: 1,641.00
Low: 1,611.00
Prev. Close: 1,640.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GSK Board change

29 Jul 2022 10:00

RNS Number : 2392U
GSK PLC
29 July 2022
 

Issued: 29 July 2022, London UK

 

GSK Board change

 

 

 

 

GSK plc (LSE/NYSE: GSK) has today announced that Dr Laurie Glimcher has advised the Company of her intention to retire from the Board on 13 October 2022 after over 5 years as a Non-Executive Director and designated Scientific and Medical Expert.

 

GSK expects to announce further Non-Executive Director appointments in due course.

 

 

Victoria Whyte

Company Secretary

29 July 2022

 

 

Notes

 

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com/company

 

GSK enquiries

Media:

Tim Foley

+44 (0) 20 8047 5502

(London)

Kathleen Quinn

+1 202 603 5003

(Washington DC)

 

Investor Relations:

Nick Stone

+44 (0) 7717 618834

(London)

James Dodwell

+44 (0) 20 8047 2406

(London)

Mick Readey

+44 (0) 7990 339653

(London)

Josh Williams

+44 (0) 7385 415719

(London)

Jeff McLaughlin

+1 215 751 7002

(Philadelphia)

 

Cautionary statement regarding forward-looking statements

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the Company's Annual Report on Form 20-F for 2021, GSK's Q2 Results for 2022 and any impacts of the COVID-19 pandemic.

 

Registered in England & Wales:

No. 3888792

 

Registered Office:

980 Great West Road

Brentford, Middlesex

TW8 9GS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEUSAUEESEFW
101112131415161718
Date   Source Headline
29th Apr 202012:00 pmRNS1st Quarter Results
29th Apr 202011:00 amRNSArrangements for Shareholder Webcast
16th Apr 20203:25 pmRNSDirector/PDMR Shareholding
16th Apr 20202:21 pmRNSDirector/PDMR Shareholding
16th Apr 20201:49 pmRNSDirector/PDMR Shareholding
14th Apr 20204:35 pmRNSDirector/PDMR Shareholding
14th Apr 20204:31 pmRNSDirector/PDMR Shareholding
14th Apr 20203:09 pmRNSDirector/PDMR Shareholding
14th Apr 202012:00 pmRNSSanofi and GSK collaboration to fight COVID-19
9th Apr 202011:52 amRNSAGM - Change of Arrangements
6th Apr 20201:00 pmRNSGSK and Vir Biotechnology enter collaboration
1st Apr 202012:57 pmRNSGSK completes divestment of Horlicks
1st Apr 202011:11 amRNSTotal Voting Rights
30th Mar 20204:06 pmRNSConsumer Healthcare product sales category changes
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSPublication of AGM Notice
20th Mar 20202:00 pmRNSDirectorate Change
18th Mar 202012:20 pmRNSDirector/PDMR Shareholding
13th Mar 20205:24 pmRNSEMTN Prospectus Supplement Update
11th Mar 20205:00 pmRNSDirector/PDMR Shareholding
9th Mar 20204:15 pmRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSPublication of GSK 2019 Form 20-F
4th Mar 20202:53 pmRNSAnnual Financial Report
2nd Mar 202011:00 amRNSTotal Voting Rights
21st Feb 20201:00 pmRNSDirector/PDMR Shareholding
20th Feb 20203:30 pmRNSDirector/PDMR Shareholding
20th Feb 20202:00 pmRNSDirector/PDMR Shareholding
20th Feb 20202:00 pmRNSDirector/PDMR Shareholding
19th Feb 20205:25 pmRNSDirector/PDMR Shareholding
19th Feb 20204:35 pmRNSDirector/PDMR Shareholding
19th Feb 20204:28 pmRNSDirector/PDMR Shareholding
19th Feb 20204:24 pmRNSDirector/PDMR Shareholding
19th Feb 20204:17 pmRNSDirector/PDMR Shareholding
12th Feb 20205:05 pmRNSDirector/PDMR Shareholding
11th Feb 20202:15 pmRNSDirector/PDMR Shareholding
11th Feb 20207:00 amRNSTransfer of Treasury Shares
6th Feb 20204:00 pmRNSDirector/PDMR Shareholding
5th Feb 20204:15 pmRNSDirector/PDMR Shareholding
5th Feb 202012:00 pmRNSFinal Results
3rd Feb 20203:15 pmRNSGSK publishes provisional 2020 Dividend Dates
3rd Feb 20209:30 amRNSTotal Voting Rights
15th Jan 20207:00 amRNSDirector/PDMR Shareholding
14th Jan 20204:46 pmRNSDirector/PDMR Shareholding
14th Jan 20204:01 pmRNSDirector/PDMR Shareholding
13th Jan 20206:00 pmRNSDirector/PDMR Shareholding
13th Jan 202011:41 amRNSDirector/PDMR Shareholding
13th Jan 202011:01 amRNSDirector/PDMR Shareholding
101112131415161718

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.